Zenotech Laboratories share price
You have to be logged in to add this to Watchlist.- ₹60.73(2.36%)May 16, 2025 15:57:26 PM IST
- NSE
- BSE
- Vol : 25.64K (NSE + BSE)Last 20 day avg : 11.94 K
Zenotech Laboratories is trading 2.36% upper at Rs 60.73 as compared to its last closing price. Zenotech Laboratories has been trading in the price range of 61.86 & 58.30. Zenotech Laboratories has given -15.64% in this year & 13.39% in the last 5 days. Zenotech Laboratories has TTM P/E ratio 57.05 as compared to the sector P/E of 35.41.The company posted a net profit of 1.23 Crores in its last quarter.Listed peers of Zenotech Laboratories include Lyka Labs (5.65%), Titan Biotech (-0.63%), Zenotech Laboratories (2.36%).The Mutual Fund holding in Zenotech Laboratories was at -% in . The MF holding has - from the last quarter. The FII holding in Zenotech Laboratories was at -% in . The FII holding has - from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Updated on May 17, 2025, 03:47 AM UTC
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- P/BIn line with historical values3.86The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/EHigher than historical values66.74Price-to-earnings ratio based on trailing 12-month earnings
- BetaLow volatility0.63Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityLower than industry0.00The debt-to-equity ratio, indicating a company's financial leverage.
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
- Income
- Balance Sheet
- Cash Flow
- Financial
- Valuation
Company is profitable- The company's revenue grew in March quarter by 33.20% from Rs 12.13 crore to Rs 9.11 crore, year-on-year
- The company has grown its March quarter profit by 86.50% from Rs 0.66 crore to Rs 1.23 crore, year-on-year
- R1
- 61.04
- R2
- 66.63
- R3
- 71.40
- S1
- 50.68
- S2
- 45.91
- S3
- 40.32
- Very Bearish
- Bearish
- Neutral
- Very Bullish
- Bullish
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Lyka Labs | Neutral | 117.85 | 5.65 | 418.91 | - | 5.42 | - | 64.80 |
| Titan Biotech | Neutral | 478.15 | -0.63 | 395.13 | 16.00 | 2.98 | 0.42 | 0.86 |
| Zenotech Laboratories | Moderately Bullish | 60.73 | 2.36 | 369.64 | 78.63 | 3.77 | - | - |
| Fredun Pharmaceuticals | Bearish | 690.00 | -1.07 | 324.61 | 20.98 | 2.7 | 0.10 | 10.54 |
| Oxygenta Pharmaceutical | Bullish | 88.15 | -0.96 | 326.01 | - | - | - |
- Promoter(s) holds a high stake in the company at 68.84%
FIIs are not invested in this company- Mutual Funds are not invested in this company.
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-04-25 | Audited Results |
| 2025-01-28 | Quarterly Results |
| 2024-10-23 | Quarterly Results |
| 2024-07-26 | Quarterly Results |
| 2024-05-01 | Audited Results |
- IndustryBiotechnology & Drugs
- ISININE486F01012
- BSE Code532039
- NSE Code
Zenotech Laboratories is trading at 60.73 as on Fri May 16 2025 10:27:26. This is 2.36% upper as compared to its previous closing price of 59.33.
The market capitalization of Zenotech Laboratories is 369.64 Cr as on Fri May 16 2025 10:27:26.
The 52 wk high for Zenotech Laboratories is 107.79 whereas the 52 wk low is 51.00
Zenotech Laboratories can be analyzed on the following key metrics -
- TTM P/E: 57.05
- Sector P/E: 35.41
- Dividend Yield: 0.00%
- D/E ratio: 0.00
Zenotech Laboratories reported a net profit of 5.61 Cr in 2025.